Inogen, Inc. (INGN) Stock Forecast

NASDAQ: INGNAnalyst ratings, price target and estimates.

INGN analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.50 / 5 from 2 analysts
Price target
$12.00
average of analyst targets
Upside to target
+92.0%
from the latest close
Next earnings
November 4, 2026
52-week range
$5.09 – $8.95

INGN analyst ratings

2 analysts
Strong buy
150%
Buy
150%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

INGN price target

Price $6.25Target $12.00
52-week low $5.0952-week high $8.95

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

INGN earnings per share estimates

Inogen, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.06−$0.06−$0.06−$0.02−200.0%1
Current fiscal year (2026)−$0.28−$0.28−$0.28−$0.30+6.7%1
Next fiscal year (2027)−$0.16−$0.16−$0.16−$0.28+42.9%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

INGN revenue estimates

Inogen, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$92.2M$92.2M$92.3M−0.1%2
Current fiscal year (2026)$356.4M$355.1M$357.7M+2.2%2
Next fiscal year (2027)$372.6M$368.1M$377.1M+4.5%2

INGN EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

INGN revenue: reported and forecast

Reported revenueEstimate (average; low–high)

INGN EPS estimate revisions

Inogen, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$0.00$0.00$0.00$0.01−$0.06—0 up · 1 down
Current fiscal year (2026)−$0.37−$0.37−$0.37−$0.28−$0.28−24.3%0 up · 1 down
Next fiscal year (2027)−$0.26−$0.26−$0.26−$0.16−$0.16−38.5%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

INGN earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; INGN beat in 10 of 12.

What analysts expect from INGN

2 analysts cover Inogen; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.00, 92.0% above the latest close of $6.25. Analysts expect earnings of −$0.28 per share for 2026, +6.7% from a year earlier. For 2027 the average estimate is −$0.16 per share on revenue of $372.6 million. Inogen beat the EPS estimate in 10 of the last 12 quarters.

Related: INGN income statement, INGN key metrics, INGN chart. See the INGN stock overview for the latest quote and news.

INGN forecast FAQ

What is Inogen's price target?

The average analyst price target for Inogen is $12.00, 92.0% above the latest close of $6.25.

Is Inogen a buy, hold or sell?

Of 2 analysts covering Inogen, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Inogen's EPS forecast?

Analysts forecast −$0.28 per share for 2026 (range −$0.28 to −$0.28); for 2027 the estimate is −$0.16.

What is Inogen's revenue forecast?

The average revenue estimate for 2026 is $356.4 million, growth of 2.2%; for 2027 it is $372.6 million.

When does Inogen report earnings?

Inogen is expected to report results for the quarter ending September 30, 2026 on November 4, 2026.

Does Inogen usually beat earnings estimates?

Inogen reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Medical Devices: forecast